ImageneBio Valuation
| IMA Stock | 6.76 0.14 2.03% |
At this time, the firm appears to be overvalued. ImageneBio retains a regular Real Value of USD5.48 per share. The prevalent price of the firm is USD6.76. Our model calculates the value of ImageneBio from evaluating the firm fundamentals such as Shares Owned By Institutions of 33.98 %, operating margin of (5.01) %, and Current Valuation of 111.51 M as well as inspecting its technical indicators and probability of bankruptcy.
Overvalued
Today
Please note that ImageneBio's price fluctuation is slightly risky at this time. Calculation of the real value of ImageneBio is based on 3 months time horizon. Increasing ImageneBio's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since ImageneBio is currently traded on the exchange, buyers and sellers on that exchange determine the market value of ImageneBio Stock. However, ImageneBio's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 6.76 | Real 5.48 | Hype 6.75 | Naive 6.7 |
The real value of ImageneBio Stock, also known as its intrinsic value, is the underlying worth of ImageneBio Company, which is reflected in its stock price. It is based on ImageneBio's financial performance, growth prospects, management team, or industry conditions. The intrinsic value of ImageneBio's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of ImageneBio helps investors to forecast how ImageneBio stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of ImageneBio more accurately as focusing exclusively on ImageneBio's fundamentals will not take into account other important factors: ImageneBio Total Value Analysis
ImageneBio is currently expected to have company total value of 111.51 M with market capitalization of 91.69 M, debt of 7.52 M, and cash on hands of . Please note that company total value may be misleading and is a subject to accounting gimmicks. We encourage investors to carefully check all of the ImageneBio fundamentals before making security assessment based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
111.51 M | 91.69 M | 7.52 M |
ImageneBio Investor Information
About 14.0% of the company shares are held by company insiders. The company recorded a loss per share of 4.33. ImageneBio had not issued any dividends in recent years. The entity had 1:12 split on the 28th of July 2025. Based on the analysis of ImageneBio's profitability, liquidity, and operating efficiency, ImageneBio is not in a good financial situation at this time. It has a very high odds of going through financial crisis in February.ImageneBio Asset Utilization
The concept of asset utilization usually refers to the revenue earned for every dollar of assets a company currently reports. The current return on assets of ImageneBio suggests not a very effective usage of assets in January.ImageneBio Ownership Allocation
The market capitalization of ImageneBio is USD91.69 Million. 30% of ImageneBio outstanding shares are owned by outside corporations. Institutional investors are typically referred to investors that purchase positions in a given stock to benefit from reduced commissions. Consequently, institutional investors are subject to different rules and regulations than regular investors. Please look out for any change in current institutional holding as this could mean something significant has changed at the company or is about to change. Note, that even with negative profits, if the true value of the firm is larger than the current market value, you may still be able to generate positive returns on investment in this company.ImageneBio Profitability Analysis
The company reported the last year's revenue of 3.5 M. Reported Net Loss for the year was (49.23 M) with profit before taxes, overhead, and interest of 4.3 M.Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates ImageneBio's worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in ImageneBio and how it compares across the competition.
About ImageneBio Valuation
The stock valuation mechanism determines ImageneBio's current worth on a weekly basis. Our valuation model uses a comparative analysis of ImageneBio. We calculate exposure to ImageneBio's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of ImageneBio's related companies.Complementary Tools for ImageneBio Stock analysis
When running ImageneBio's price analysis, check to measure ImageneBio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy ImageneBio is operating at the current time. Most of ImageneBio's value examination focuses on studying past and present price action to predict the probability of ImageneBio's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move ImageneBio's price. Additionally, you may evaluate how the addition of ImageneBio to your portfolios can decrease your overall portfolio volatility.
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals |